Drug Trials Snapshots: BALVERSA
BALVERSA is a drug for the treatment of a type of bladder and urinary tract cancer called urothelial carcinoma. BALVERSA may be used in patients with urothelial carcinoma:
whose tumors have a certain type of abnormal (FGFR) gene and
whose cancer has spread (locally advanced or metastatic urothelial
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: FDA Source Type: news
More News: Bladder Cancer | Cancer | Cancer & Oncology | Carcinoma | Drugs & Pharmacology | Genetics